
Gujarat launches drive to eradicate measles, rubella by 2026
Gandhinagar: The state govt on Thursday announced that it will launch an intensive drive to immunise children against measles and rubella, aiming to eradicate the diseases in the state by 2026.
State health minister Rushikesh Patel and officials from the state health department virtually joined the 'Measles and Rubella Eradication Campaign 2025-26', launched from New Delhi by union health minister J P Nadda on Thursday.
You Can Also Check:
Ahmedabad AQI
|
Weather in Ahmedabad
|
Bank Holidays in Ahmedabad
|
Public Holidays in Ahmedabad
As part of the universal immunisation programme in the state, the first dose of the measles and rubella vaccine is given to a child at 9-12 months, and the second dose at 16-24 months to ensure protection. In Gujarat, cases of measles decreased from about 4,000 in 2023 to just 471 in 2024, the govt stated.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
10 Mysterious Photos That Cannot Be Explained
True Edition
Undo
The govt statement added that earlier, a strategy for measles and rubella eradication was prepared, and instructions for implementation were given during a meeting chaired by the chief secretary with collectors, municipal commissioners, district development officers, and other officials.
The govt mentioned that regular surveillance by districts and municipal corporations will be intensified, and weekly reviews via video conferencing will be conducted. Additionally, an intensive 'Mission Indradhanush' will be conducted from Aug to Oct this year for all unvaccinated children, and special immunisation weeks will be held four times a year.
Under the 'Khilkhilat' drive earlier this year, a special campaign was held from Jan 16 to 22, where 25,736 children were vaccinated. During the measles-rubella drive on March 15 and 16, 29,238 children were vaccinated, the statement said.
Gujarat minister Patel stated that vaccination analysis will be conducted at the village level to achieve a 95% target for MR 1 and MR 2 vaccinations in all districts and municipal corporations. He added that as part of the World Immunisation Week, which is being observed from April 24 to 30, special vaccination drives have been planned across the state.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
an hour ago
- Time of India
RFK Jr ousts entire US vaccine panel over alleged conflicts
US Health Secretary Robert F. Kennedy Jr. on Monday announced he was dismissing all current members of a key federal vaccine advisory panel, accusing them of conflicts of interest -- his latest salvo against the nation's immunization policies. The removal of all 17 experts of the Advisory Committee on Immunization Practices (ACIP) was revealed in a Wall Street Journal op-ed and an official press release. Kennedy, who has spent two decades promoting vaccine misinformation, cast the move as essential to restoring public trust, claiming the committee had been compromised by financial ties to pharmaceutical companies. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Live Comfortably: 60 m² Prefab Bungalow for Seniors in Santa Mesa Pre Fabricated Homes | Search Ads Search Now Undo "Today we are prioritizing the restoration of public trust above any specific pro- or anti-vaccine agenda," he said in a statement from the Department of Health and Human Services. "The public must know that unbiased science -- evaluated through a transparent process and insulated from conflicts of interest - guides the recommendations of our health agencies." Live Events In his op-ed, Kennedy claimed the panel was "plagued with persistent conflicts of interest" and had become "little more than a rubber stamp for any vaccine." He added that new members were being considered to replace those ousted -- all of whom were appointed under former president Joe Biden . ACIP members are chosen for their recognized expertise and are required to disclose potential conflicts of interest. " RFK Jr . and the Trump administration are taking a wrecking ball to the programs that keep Americans safe and healthy," Senate Democratic Leader Chuck Schumer said in response. "Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion," Republican Senator Bill Cassidy, a medical doctor who expressed concern about Kennedy's track record during his Senate nomination but ultimately voted in his favor, wrote on X. "I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case." 'Silencing expertise' The decision drew sharp criticism from Paul Offit, a pediatrician and leading expert on virology and immunology who served on the panel from 1998 to 2003. "He believes that anybody who speaks well of vaccines, or recommends vaccines, must be deeply in the pocket of industry," Offit told AFP. "He's fixing a problem that doesn't exist." "We are witnessing an escalating effort by the Administration to silence independent medical expertise and stoke distrust in lifesaving vaccines," added Susan Kressly, president of the American Academy of Pediatrics, in a statement. Once a celebrated environmental lawyer, Kennedy pivoted from the mid-2000s to public health -- chairing a nonprofit that discouraged routine childhood immunizations and amplified false claims, including the long-debunked theory that the Measles, Mumps and Rubella (MMR) vaccine causes autism. Since taking office, he has curtailed access to Covid-19 shots and continued to raise fears around the MMR vaccine -- even as the United States faces its worst measles outbreak in years, with three reported deaths and more than 1,100 confirmed cases. Experts warn the true case count is likely far higher. "How can this country have confidence that the people RFK Jr. wants on the Advisory Committee for Immunization Practices are people we can trust?" Offit asked. He recalled that during US President Donald Trump 's first term, several states formed independent vaccine advisory panels after the administration pressured federal health agencies to prematurely approve Covid-19 vaccines ahead of the 2020 election. That kind of fragmentation, Offit warned, could happen again. ACIP is scheduled to hold its next meeting at the headquarters of the Centers for Disease Control and Prevention in Atlanta from June 25 to June 27. Vaccines for anthrax, Covid-19, human papillomavirus, influenza, Lyme disease, respiratory syncytial virus, and more are on the agenda.


Time of India
6 hours ago
- Time of India
List MBBS students or they will face practise bar: NMC to colleges
NEW DELHI: Cracking the whip, the National Medical Commission (NMC) has said that students who got admission in MBBS course in 2024-25 but whose names are missing from its portal may not be eligible for registration to practise medicine. The National Medical Commission - the apex body for regulating medical education in the country - issued the warning through a public notice after failing to receive the names and basic details of all students admitted to MBBS course in 2024-25 in medical colleges across the country. India has approximately 1.18 lakh MBBS seats. According to NMC, despite issuance of several circulars and public notices over the last eight months, details of only 1,15,250 students admitted for 2024-25 academic year have been received from medical colleges and uploaded on its portal. "Some of the colleges did not upload details of students admitted to MBBS course and some colleges uploaded incomplete data," it said. In the public notice, a copy of which is with TOI, NMC stated that only students whose details have been uploaded on the portal shall be eligible for registration to practise medicine. It has directed students whose names are missing to consult the directorate of medical education concerned or their counselling authority urgently. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video] getfittoday Undo The first deadline for submission of details - which include name of medical college, date of admission, student name, their merit number, date of birth and roll number - was Nov 8, 2024. Later, it was extended to Nov 23 and then to Dec 10. Sources said NMC's decision in Oct last year to seek details of all students admitted to MBBS course was prompted by an informal exercise it carried out to double-check that colleges made such admissions in accordance with regulations. The apex body found at least 30-40 instances where students were admitted in breach of rules. For example, a senior official said, even students who obtained less than 50% marks in 10+2 (physics, chemistry, biology) -- a basic criterion -- were granted admission. A senior NMC official highlighted that while granting admission, medical colleges are required to ensure the numbers are not beyond their sanctioned intake capacity. Also, colleges must make sure that students meet eligibility requirements regarding age and qualifying marks. All students admitted to MBBS course are supposed to have cleared NEET-UG with the required percentile: 50th percentile and above for general category, 45th percentile and above for the physically challenged and 40th percentile and above for reserved (SC/ST/OBC) candidates.


Time of India
6 hours ago
- Time of India
XFG Covid strain enters Telangana, cases still mild
1 2 Hyderabad: As concerns grow about rising Covid-19 cases in the country, for the first time, one of the samples sent by Telangana health officials for genome sequencing has been found to carry a new Covid-19 sub-variant called XFG. This was revealed by the Indian SARS-CoV-2 Genomics Consortium (INSACOG), the central body that tracks changes in the virus. Of the five samples sent from Telangana, four — two men and two women — showed another recent sub-variant called LF.7.9, while the XFG strain was detected in a sample from one man. Dr Kiran Madala, co-chairman of the public relations and social media committee of IMA Telangana and a Covid-19 researcher, confirmed to TOI that both variants were detected in Telangana and the sequences were uploaded on INSACOG's portal. Both XFG and LF.7.9 are sub-lineages of Omicron and trace their origin to the JN.1 variant, which led to a global wave in late 2023 and early 2024. Nationally, these two sub-variants are among the most common at present. As per INSACOG data till Monday, 172 samples were identified as XFG, 82 as LF.7.9, followed by 35 XFJ and 18 others. Telangana has now joined Maharashtra, Tamil Nadu, Kerala, Gujarat, Andhra Pradesh, Madhya Pradesh, and West Bengal, where the XFG variant has already been detected. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Thị trường có dấu hiệu suy thoái không? IC Markets Đăng ký Undo Across India, around 163 cases of XFG have been recorded so far, as per INSACOG. The World Health Organization (WHO) is currently tracking eight sub-variants globally, including NB.1.8.1, which is prevalent in Singapore. "There are ongoing studies on the transmissibility and impact of XFG, LF.7.9, and XFJ. So far, they appear mild. WHO hasn't issued any special advisory on them yet," said Dr Kiran Madala, who is also a professor at Gandhi Medical College. "Covid-19 has become endemic and is not severe in most cases," he added. While the majority of cases remain mild, experts advise caution for vulnerable groups. "According to Indian Council of Medical Research (ICMR) data, 66% of current respiratory viral infections in India are Covid-related. However, hospitalisation is low, including in Telangana. People with two or more comorbidities, weakened immunity, or above 70 years should remain alert," he said. Telangana currently has nine active Covid cases, down from 10 a day earlier, according to the Union health ministry dashboard. "There's no reason to panic," said Dr Ravinder Nayak, director of public health and family welfare. "The new sub-variants are part of the virus's natural evolution and are not showing significant clinical symptoms."